ENERGIZE-T: A Global, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-ThalassemiaMaria Domenica Cappellini, Antonis Kattamis, Giovanna Cannas et al.|Blood|2024Cited by 14
P112: ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON--TRANSFUSION-DEPENDENT OR TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIAKevin H.M. Kuo, Maria Domenica Cappellini, D. Mark Layton et al.|HemaSphere|2022Cited by 6
Efficacy of mitapivat in patients with transfusion-dependent alpha-thalassemia: Subgroup analysis from the ENERGIZE-T trialAshutosh Lal, Vip Viprakasit, Andreas Glenthøj et al.|Blood|2025Cited by 2